Clinical Practice Guidelines for supplemental therapies and issues (Q63681899)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18668117%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Clinical practice guidelines for supplemental therapies and issues (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18668117%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18668117%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Francois Madore

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18668117%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Scott W Klarenbach

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18668117%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Louise M Moist

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18668117%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Rob N Foley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18668117%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Brendan J Barrett

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18668117%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Colin T White

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18668117%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Bruce F Culleton

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18668117%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Braden J Manns

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18668117%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Canadian Society of Nephrology

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18668117%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 August 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18668117%20AND%20SRC:MED&resulttype=core&format=json

Kidney International. Supplement

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18668117%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

74

0 references

issue

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18668117%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

S19-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18668117%20AND%20SRC:MED&resulttype=core&format=json

A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Use of nandrolone decanoate as an adjuvant for erythropoietin dose reduction in treating anemia in patients on hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Transdermal androgen therapy to augment EPO in the treatment of anemia of chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Carnitine treatment improved quality-of-life measure in a sample of Midwestern hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Ultrapure dialysate reduces dose of recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Ultrapure dialysate and inflammatory response in haemodialysis evaluated by darbepoetin requirements--a randomized study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Pentoxifylline improves hemoglobin levels in patients with erythropoietin-resistant anemia in renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Vitamin B(6) therapy does not improve hematocrit in hemodialysis patients supplemented with iron and erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Challenging the validity of the EPO index

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

The CARI guidelines. Biochemical and haematological targets guidelines. Haemoglobin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Correction of anemia with epoetin alfa in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Use of EPO in critically ill patients with acute renal failure requiring renal replacement therapy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Avoiding a blood transfusion: How much is it worth?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Erythropoietin and acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.271

7 January 2021

Identifiers

DOI

10.1038/KI.2008.271

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18668117%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference